Fine Organic Industries Limited has informed the Exchange about Transcript
FINEORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fine Organic Industries (FINEORG) filed the transcript of its Q4 FY25 annual earnings call. FY25 revenue grew 6.9% to INR 2,269 cr, but EBITDA fell 4% to INR 512.9 cr with margins at 22.6%, as rising raw material prices, elevated logistics costs in H1, and higher utility costs pressured profitability. Management outlined a large capex plan of INR 700-750 cr for a new SEZ manufacturing facility at JNPA (18-24 month construction), alongside plans to set up a wholly-owned U.S. manufacturing subsidiary and a UAE entity, plus a small super-specialty expansion in Thailand. All Indian plants are running near full capacity, with Patalganga expected to fill up by FY26/H1 FY27, so the company is largely not onboarding new large customers until new capacity arrives. Cash on books is around INR 1,150-1,200 cr, which will partly fund expansion, with management also open to debt and actively exploring complementary M&A opportunities.
Near-term margins remain under pressure from raw material inflation and one-year contracts that absorbed cost hikes, while the heavy capex cycle (INR 700-750 cr for JNPA plus U.S. build-out) may compress returns over the next 2-3 years. On the positive side, the large capacity expansion and potential M&A pipeline position Fine Organic for a meaningful growth step-up once new plants commission.